82 FR 42559 - Proposed Collection; 30-Day Comment Request; Application To Participate in the National Institutes of Health Technical Assistance Programs: Commercialization Accelerator Program (CAP)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 173 (September 8, 2017)

Page Range		42559-42560
FR Document		2017-19078

In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on June 15, 2017, page 27516 (82 FR 27516) and allowed 60 days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment.

Federal Register, Volume 82 Issue 173 (Friday, September 8, 2017)

[Federal Register Volume 82, Number 173 (Friday, September 8, 2017)]
[Notices]
[Pages 42559-42560]
From the Federal Register Online [www.thefederalregister.org]
[FR Doc No: 2017-19078]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

Proposed Collection; 30-Day Comment Request; Application To
Participate in the National Institutes of Health Technical Assistance
Programs: Commercialization Accelerator Program (CAP)

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

[[Page 42560]]

SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below. This proposed information
collection was previously published in the Federal Register on June 15,
2017, page 27516 (82 FR 27516) and allowed 60 days for public comment.
No public comments were received. The purpose of this notice is to
allow an additional 30 days for public comment.

DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30-days of the date of
this publication.

ADDRESSES: Written comments and/or suggestions regarding the item(s)
contained in this notice, especially regarding the estimated public
burden and associated response time, should be directed to the: Office
of Management and Budget, Office of Regulatory Affairs,
OIRA_submission@omb.eop.gov or by fax to 202-395-6974, Attention: Desk
Officer for NIH.

FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: J. P. Kim, NIH SBIR/STTR Program Manager & NIH
Extramural Data Sharing Policy Officer, Small Business Innovation
Research (SBIR) and Small Business Technology Transfer (STTR) Program
Office, Office of Extramural Programs (OEP)/Office of Extramural
Research (OER), Office of the Director (OD)/National Institutes of
Health (NIH), 6705 Rockledge Drive, Suite 350; Bethesda, Maryland
20892-7963 or call non-toll-free number (301) 435-0189 or Email your
request, including your address to: jpkim@nih.gov. Formal requests for
additional plans and instruments must be requested in writing.

SUPPLEMENTARY INFORMATION: The Commercialization Accelerator Program
(CAP), National Institutes of Health, may not conduct or sponsor, and
the respondent is not required to respond to, an information collection
that has been extended, revised, or implemented on or after October 1,
1995, unless it displays a currently valid OMB control number.
In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) has submitted to
the Office of Management and Budget (OMB) a request for review and
approval of the information collection listed below.
Proposed Collection: Application to Participate in the National
Institutes of Health Technical Assistance Programs: Commercialization
Accelerator Program (CAP)--0925--Existing Without OMB Approval, Office
of Extramural Programs (OEP)/Office of Extramural Research (OER),
Office of the Director (OD)/National Institutes of Health.
Need and Use of Information Collection: The purpose of this
application is to collect information to be used internally by the NIH
SBIR/STTR staff to identify and select small businesses that would most
benefit if selected as participants in the NIH Commercialization
Accelerator Program (CAP). The data will not be used to formulate or
change policies. Rather, it will be used to enable NIH SBIR/STTR staff
to be responsive to its constituents by offering commercialization
training to meet the goals of the Phase II small business NIH awardees.
The form will be online for any potential CAP applicant companies and
completed electronically.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 150.

Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Type of respondent Number of responses per Average time Total annual
respondents respondent per response burden hour
----------------------------------------------------------------------------------------------------------------
SBIR Phase II Awardees.......................... 100 1 90 150
---------------------------------------------------------------
Total....................................... 100 100 .............. 150
----------------------------------------------------------------------------------------------------------------

Dated: September 1, 2017.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2017-19078 Filed 9-7-17; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 173 / Friday, September 8, 2017 / Notices 42559

go/connectpro_overview. FDA has The meeting will be closed to the would constitute a clearly unwarranted
verified the Web site addresses in this public in accordance with the invasion of personal privacy.
document, as of the date this document provisions set forth in sections Name of Committee: National Cancer
publishes in the Federal Register, but 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Institute Special Emphasis Panel; Pancreatic
Web sites are subject to change over as amended. The contract proposals and Cancer Detection Consortium (U01).
time. the discussions could disclose Date: November 3, 2017.
Transcripts: Please be advised that as confidential trade secrets or commercial Time: 11:00 a.m. to 2:00 p.m.
soon as a transcript of the public property such as patentable material, Agenda: To review and evaluate grant
applications.
workshop is available, it will be and personal information concerning Place: National Cancer Institute, Shady
accessible at https:// individuals associated with the contract Grove, 9609 Medical Center Drive, Room
www.regulations.gov. It may be viewed proposals, the disclosure of which 7W240, Rockville, MD 20850, (Telephone
at the Dockets Management Staff (see would constitute a clearly unwarranted Conferece Call).
ADDRESSES). A link to the transcript will invasion of personal privacy. Contact Person: Hasan Siddiqui, Ph.D.,
also be available on the Internet at Scientific Review Officer, Special Review
Name of Committee: National Heart, Lung,
https://www.fda.gov/MedicalDevices/ Branch, Division of Extramural Activities,
and Blood Institute Special Emphasis Panel;
National Cancer Institute, NIH, 9609 Medical
NewsEvents/WorkshopsConferences/ Resources for Clinical Trials.
Center Drive, Room 7W240, Bethesda, MD
default.htm. Date: September 20, 2017.
20892–9750, 240–276–5122, hasan.siddiqui@
Time: 11:00 a.m. to 1:00 p.m.
IV. References nih.gov.
Agenda: To review and evaluate contract
proposals. Name of Committee: National Cancer
The following references are on Institute Special Emphasis Panel;
Place: National Institutes of Health, 6701
display in the Dockets Management Rockledge Drive, Room 7200, Bethesda, MD Cooperative Agreement To Develop Targeted
Staff (see ADDRESSES) and are available 20892 (Telephone Conference Call). Agents Used With Systemic Agents Plus
for viewing by interested persons Contact Person: Michael P. Reilly, Ph.D., Radiotherapy.
between 9 a.m. and 4 p.m., Monday Scientific Review Officer, Office of Scientific Date: November 17, 2017.
through Friday; they are also available Review/DERA, National Heart, Lung, and Time: 10:00 a.m. to 2:00 p.m.
Blood Institute, 6701 Rockledge Drive, Room Agenda: To review and evaluate grant
electronically at https:// applications.
www.regulations.gov. FDA has verified 7200, Bethesda, MD 20892, 301–827–7975,
reillymp@nhlbi.nih.gov. Place: National Cancer Institute, Shady
the Web site addresses, as of the date Grove, 9609 Medical Center Drive, Room
this document publishes in the Federal This notice is being published less than 15 7W640, Rockville, MD 20850, (Telephone
Register, but Web sites are subject to days prior to the meeting due to the timing Conferece Call).
limitations imposed by the review and Contact Person: Saejeong J. Kim, Ph.D.,
change over time. funding cycle. Scientific Review Officer, Resources and
1. National Cancer Institute, ‘‘Cancer Stat (Catalogue of Federal Domestic Assistance Training Review Branch, Division of
Facts: Cervix Uteri Cancer,’’ (http:// Program Nos. 93.233, National Center for Extramural Activities, National Cancer
seer.cancer.gov/statfacts/html/ Sleep Disorders Research; 93.837, Heart and Institute, NIH, 9609 Medical Center Drive,
cervix.html). Vascular Diseases Research; 93.838, Lung Room 7W640, Bethesda, MD 20892–9750,
2. Horner, M.J., S.F. Altekruse, Z. Zou, L. Diseases Research; 93.839, Blood Diseases 240–276–7684, saejeong.kim@nih.gov.
Wideroff, et al. ‘‘U.S. Geographic and Resources Research, National Institutes (Catalogue of Federal Domestic Assistance
Distribution of Pre-Vaccine Era Cervical of Health, HHS) Program Nos. 93.392, Cancer Construction;
Cancer Screening, Incidence, Stage, and 93.393, Cancer Cause and Prevention
Mortality.’’ Cancer Epidemiology, Dated: September 1, 2017.
Research; 93.394, Cancer Detection and
Biomarkers & Prevention. 2011 Jan.; Michelle Trout,
Diagnosis Research; 93.395, Cancer
20(4):591–9. doi: 10.1158/1055–9965. Program Analyst, Office of Federal Advisory Treatment Research; 93.396, Cancer Biology
EPI–10–1183. Committee Policy. Research; 93.397, Cancer Centers Support;
3. Freeman, H.W.B. ‘‘Excess Cervical Cancer [FR Doc. 2017–19027 Filed 9–7–17; 8:45 am] 93.398, Cancer Research Manpower; 93.399,
Mortality: A Marker for Low Access to Cancer Control, National Institutes of Health,
BILLING CODE 4140–01–P
Health Care in Poor Communities.’’ HHS)
Rockville (MD): National Cancer
Institute, Center to Reduce Cancer Health Dated: September 1, 2017.
Disparities; 2005. DEPARTMENT OF HEALTH AND Melanie J. Pantoja,
HUMAN SERVICES Program Analyst, Office of Federal Advisory
Dated: September 1, 2017.
Committee Policy.
Anna K. Abram, National Institutes of Health
[FR Doc. 2017–19026 Filed 9–7–17; 8:45 am]
Deputy Commissioner for Policy, Planning,
Legislation, and Analysis. National Cancer Institute; Notice of BILLING CODE 4140–01–P

[FR Doc. 2017–19029 Filed 9–7–17; 8:45 am] Closed Meetings
BILLING CODE 4164–01–P Pursuant to section 10(d) of the DEPARTMENT OF HEALTH AND
Federal Advisory Committee Act, as HUMAN SERVICES
amended, notice is hereby given of the
DEPARTMENT OF HEALTH AND following meetings. National Institutes of Health
HUMAN SERVICES The meetings will be closed to the
public in accordance with the Proposed Collection; 30-Day Comment
National Institutes of Health provisions set forth in sections Request; Application To Participate in
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., the National Institutes of Health
sradovich on DSK3GMQ082PROD with NOTICES

National Heart, Lung, and Blood
as amended. The grant applications and Technical Assistance Programs:
Institute; Notice of Closed Meeting
the discussions could disclose Commercialization Accelerator
Pursuant to section 10(d) of the confidential trade secrets or commercial Program (CAP)
Federal Advisory Committee Act, as property such as patentable material, AGENCY: National Institutes of Health,
amended, notice is hereby given of a and personal information concerning HHS.
meeting of the NHLBI Special Emphasis individuals associated with the grant
ACTION: Notice.
Panel. applications, the disclosure of which

VerDate Sep<11>2014 17:18 Sep 07, 2017 Jkt 241001 PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 E:\FR\FM\08SEN1.SGM 08SEN1

Document Created: 2018-10-24 14:09:38
Document Modified: 2018-10-24 14:09:38

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Dates		Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication.
Contact		To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: J. P. Kim, NIH SBIR/STTR Program Manager & NIH Extramural Data Sharing Policy Officer, Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Program Office, Office of Extramural Programs (OEP)/Office of Extramural Research (OER), Office of the Director (OD)/National Institutes of Health (NIH), 6705 Rockledge Drive, Suite 350; Bethesda, Maryland 20892-7963 or call non-toll-free number (301) 435-0189 or Email your
FR Citation		82 FR 42559

82 FR 42559 - Proposed Collection; 30-Day Comment Request; Application To Participate in the National Institutes of Health Technical Assistance Programs: Commercialization Accelerator Program (CAP)

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 173 (September 8, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health